Skip to main content

Table 1 Baseline characteristics of study subjects, determined at screening before commencement of the diets

From: Distinct osmoregulatory responses to sodium loading in patients with altered glycosaminoglycan structure: a randomized cross-over trial

 

Type 1 diabetes patients (n = 8)

HME patients (n = 7)

Healthy controls (n = 11)

Age (year)

28.1 (2.0)*

26.6 (3.2)

22.7 (1.2)

BMI (kg/m2)

22.8 (0.9)

24.4 (1.1)

22.0 (0.6)

Total body weight (kg)

77.4 (3.3)

78.8 (2.8)

75.7 (2.0)

Hematocrit (L/L)

0.45 (0.01)*

0.44 (0.01)

0.43 (0.01)

Glucose (mmol/L)

8.1 (1.5)*

4.7 (0.2)

5.1 (0.2)

Plasma sodium (mmol/L)

139.0 (0.5)

140.1 (0.3)

140.0 (0.5)

Plasma potassium (mmol/L)

4.4 (0.1)

4.0 (0.1)

4.2 (0.1)

Plasma osmolality (mOsm/kg)

295 (2)

290 (1)

287 (5)

Plasma creatinine (umol/L)

72 (3)*

73 (2)*

81 (3)

Urine sodium (mmol/24 h)

193 (28)

154 (24)

166 (20)

Urine potassium (mmol/24 h)

74 (14)

72 (4)

71 (5)

Supine systolic blood pressure (mmHg)

124 (2)

118 (2)

121 (3)

Supine diastolic blood pressure (mmHg)

64 (3)

63 (2)

59 (2)

Supine heart rate (bpm)

56 (2)

64 (4)

61 (2)

  1. Data are depicted as mean (SEM). Data were tested using an unpaired t-test compared to controls. *P < 0.05 vs. healthy controls